LA
CELU icon

Linden Advisors’s Celularity CELU Stock Holding History

Linden Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-70,565
Closed -$7.11M – 827
2021
Q1 		$7.11M Buy
70,565
+18,788
+36% +$1.93M 0.05% 221
2020
Q4 		$5.7M Hold
51,777
– – 0.04% 226
2020
Q3 		$5.44M Buy
51,777
+25,030
+94% +$2.59M 0.07% 150
2020
Q2 		$2.73M Buy
26,747
+4,464
+20% +$443K 0.04% 139
2020
Q1 		$2.18M Sell
22,283
-235,317
-91% -$23.3M 0.04% 130
2019
Q4 		$25.8M Buy
257,600
+6,250
+2% +$620K 0.31% 68
2019
Q3 		$25M Buy
+251,350
New +$24.7M 0.34% 66

Other funds holding CELU

WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Linden Advisors's CELU Position: Q2 2021 in Review

Linden Advisors sold out of Celularity (CELU) in Q2 2021, closing a stake of 70,565 shares — an estimated $7.11M sold.

Linden Advisors first reported a position in CELU in Q3 2019 and held it in 7 quarters. The position peaked at $25.8M in Q4 2019. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • Linden Advisors reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • Linden Advisors sold 70,565 Celularity shares in Q2 2021, an estimated $7.11M.
  • Linden Advisors first reported a position in Celularity in Q3 2019 and held it in 7 quarters.
  • Linden Advisors's Celularity position peaked at $25.8M in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Linden Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.